Interaction Checker

Add peptides or compounds to check all pairwise interactions, cumulative organ load, and safety flags.

This stack has significant risks: 1 interaction(s) to avoid and 1 critical warning(s). Review carefully before proceeding.
1 combination(s) marked "avoid": Finasteride + Trenbolone. Review these interactions carefully.

Cumulative Organ Load

Gonads
moderate
Heart
low
Skin
low
Liver
low

Shared Safety Flags

2x 2 estrogenic compounds (Finasteride, Trenbolone). Combined estrogen elevation — monitor E2 and consider aromatase inhibitor.
2x 2 hepatotoxic compounds (Finasteride, Trenbolone). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 compounds share the teratogenic safety flag (Finasteride, Trenbolone). Monitor accordingly.
!
Finasteride + Trenbolone
Avoid

5-alpha reductase inhibitors must be avoided with trenbolone. Unlike testosterone, where 5-AR inhibitors reduce conversion to the more potent DHT, trenbolone is not primarily metabolized by 5-alpha reductase in a beneficial way. Trenbolone's androgenic metabolites are produced through different enzymatic pathways, and blocking 5-AR can paradoxically increase androgenic side effects in certain tissues. Finasteride and dutasteride provide no protective benefit against trenbolone-related hair loss, acne, or prostate effects and may worsen them.

Researched 95% confidence Compare

Interaction data is compiled from research literature, pharmacological analysis, and community reports. Inferred interactions are based on known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.